{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,3]],"date-time":"2025-08-03T04:30:43Z","timestamp":1754195443503},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,1]]},"abstract":"<jats:p>The delay in platelet recovery after hematopoietic stem cell transplantation (HSCT) is closely related to the overall survival rate of transplanted children. The use of platelet-producing agents such as eltrombopag and romiplostim has made great progress in treating diseases such as immune thrombocytopenia and aplastic anemia. However, the use of such drugs in patients with thrombocytopenia after transplantation, especially in children, is rare. This study aimed to report eltrombopag treatment for 3 children with primary platelet engraftment failure and secondary thrombocytopenia after allogeneic HSCT. Of these patients, 2 had platelets stabilized at \u226550\u00d710<jats:sup>9<\/jats:sup>\/L after eltrombopag treatment and subsequent withdrawal of eltrombopag. All 3 patients showed no clear adverse reactions. The results indicated a wide application prospect of eltrombopag treatment in children with thrombocytopenia after allogeneic HSCT.<\/jats:p>","DOI":"10.1097\/mph.0000000000001263","type":"journal-article","created":{"date-parts":[[2018,8,5]],"date-time":"2018-08-05T23:20:16Z","timestamp":1533511216000},"page":"38-41","source":"Crossref","is-referenced-by-count":19,"title":["Eltrombopag for Delayed Platelet Recovery and Secondary Thrombocytopenia Following Allogeneic Stem Cell Transplantation in Children"],"prefix":"10.1097","volume":"41","author":[{"given":"Sidan","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Runhui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingling","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanghua","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liqiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maoquan","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230918","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.critrevonc.2016.09.004","article-title":"An overview of hematopoietic stem cell transplantation related thrombotic complications","volume":"107","author":"Sahin","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"key":"R2-20230918","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1007\/s00277-016-2767-y","article-title":"Clinical characteristics and risk factors of intracranial hemorrhage in patients following allogeneic hematopoietic stem cell transplantation","volume":"95","author":"Zhang","year":"2016","journal-title":"Ann Hematol"},{"key":"R3-20230918","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1001\/jamaoncol.2016.2466","article-title":"Different platelet count thresholds to guide use of prophylactic platelet transfusions for patients with hematological disorders after myelosuppressive chemotherapy or stem cell transplantation","volume":"2","author":"Estcourt","year":"2016","journal-title":"JAMA Oncol"},{"key":"R4-20230918","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/hon.2427","article-title":"Delayed platelet recovery after allogeneic hematopoietic stem cell transplantation: association with chronic graft-versus-host disease and survival outcome","volume":"36","author":"Akahoshi","year":"2018","journal-title":"Hematol Oncol"},{"key":"R5-20230918","first-page":"633","article-title":"Hematopoietic reconstitution and prognosis of different types of hematopoietic stem cell transplantation for severe aplastic anemia","volume":"36","author":"Lu","year":"2015","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"R6-20230918","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1111\/j.1537-2995.2011.03442.x","article-title":"Recovery, survival, and function of transfused platelets and detection of platelet engraftment after allogeneic stem cell transplantation","volume":"52","author":"Vetlesen","year":"2012","journal-title":"Transfusion"},{"key":"R7-20230918","doi-asserted-by":"crossref","first-page":"119","DOI":"10.5045\/br.2017.52.2.119","article-title":"Treatment and response of autoimmune cytopenia occurring after allogeneic hematopoietic cell transplantation in children","volume":"52","author":"Hwang-Bo","year":"2017","journal-title":"Blood Res"},{"issue":"suppl 2","key":"R8-20230918","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1016\/S0049-3848(14)50011-4","article-title":"Thrombocytopenia in cancer patients","volume":"133","author":"Liebman","year":"2014","journal-title":"Thromb Res"},{"key":"R9-20230918","doi-asserted-by":"crossref","first-page":"567","DOI":"10.2165\/00003495-200969050-00005","article-title":"Eltrombopag","volume":"69","author":"Garnock-Jones","year":"2009","journal-title":"Drugs"},{"key":"R10-20230918","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s40265-016-0581-4","article-title":"Eltrombopag: a review in paediatric chronic immune thrombocytopenia","volume":"76","author":"Burness","year":"2016","journal-title":"Drugs"},{"key":"R11-20230918","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/bjh.14515","article-title":"State of the art\u2014how I manage immune thrombocytopenia","volume":"177","author":"Cooper","year":"2017","journal-title":"Br J Haematol"},{"key":"R12-20230918","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/2040620717693573","article-title":"From chronic immune thrombocytopenia to severe aplastic anemia: recent insights into the evolution of eltrombopag","volume":"8","author":"Gill","year":"2017","journal-title":"Ther Adv Hematol"},{"key":"R13-20230918","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1182\/blood-2013-05-498279","article-title":"Management of the refractory aplastic anemia patient: what are the options?","volume":"122","author":"Marsh","year":"2013","journal-title":"Blood"},{"key":"R14-20230918","first-page":"1065","article-title":"Eltrombopag for refractory thrombocytopenia in patients with allogeneic hematopoietic stem cell transplantation","volume":"37","author":"Ma","year":"2016","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"R15-20230918","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.bbmt.2016.01.018","article-title":"Eltrombopag for treatment of thrombocytopenia after allogeneic hematopoietic cell transplantation","volume":"22","author":"Tanaka","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"R16-20230918","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/j.bbmt.2013.10.002","article-title":"A phase 1 trial of eltrombopag in patients undergoing stem cell transplantation after total body irradiation","volume":"19","author":"Liesveld","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"R17-20230918","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1182\/blood-2016-08-693481","article-title":"How I treat acquired aplastic anemia","volume":"129","author":"Bacigalupo","year":"2017","journal-title":"Blood"},{"key":"R18-20230918","doi-asserted-by":"crossref","first-page":"e13017","DOI":"10.1111\/petr.13017","article-title":"Eltrombopag for secondary failure of platelet recovery post-allogeneic hematopoietic stem cell transplant in children","volume":"21","author":"Ali","year":"2017","journal-title":"Pediatr Transplant"},{"key":"R19-20230918","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/MPH.0000000000000451","article-title":"Successful use of eltrombopag in a child with hurler syndrome after haploidentical hematopoietic stem cell transplantation","volume":"38","author":"Naithani","year":"2016","journal-title":"J Pediatr Hematol Oncol"},{"key":"R20-20230918","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1080\/17474086.2017.1313700","article-title":"Updates on the pathophysiology and treatment of aplastic anemia: a comprehensive review","volume":"10","author":"Boddu","year":"2017","journal-title":"Expert Rev Hematol"},{"key":"R21-20230918","first-page":"151","article-title":"Treatment of immune thrombocytopenic purpura: focus on eltrombopag","volume":"3","author":"Rice","year":"2009","journal-title":"Biologics"},{"key":"R22-20230918","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s12185-013-1382-0","article-title":"The biology of thrombopoietin and thrombopoietin receptor agonists","volume":"98","author":"Kuter","year":"2013","journal-title":"Int J Hematol"},{"issue":"suppl 1","key":"R23-20230918","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1053\/j.seminhematol.2013.03.005","article-title":"Thrombopoietin receptor agonists in primary immune thrombocytopenia","volume":"50","author":"Siegal","year":"2013","journal-title":"Semin Hematol"},{"key":"R24-20230918","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s00277-017-2953-6","article-title":"Beyond immune thrombocytopenia: the evolving role of thrombopoietin receptor agonists","volume":"96","author":"Rodeghiero","year":"2017","journal-title":"Ann Hematol"},{"key":"R25-20230918","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s12325-015-0251-z","article-title":"Current management of primary immune thrombocytopenia","volume":"32","author":"Provan","year":"2015","journal-title":"Adv Ther"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00043426-201901000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T04:42:36Z","timestamp":1695012156000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00043426-201901000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000001263","relation":{},"ISSN":["1077-4114"],"issn-type":[{"type":"print","value":"1077-4114"}],"subject":[],"published":{"date-parts":[[2019,1]]}}}